Equitable Holdings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Sell
28,594
-2,568
-8% -$225K 0.02% 651
2026
Q1
$2.54M Buy
31,162
+15,010
+93% +$1.34M 0.02% 642
2025
Q4
$1.28M Sell
16,152
-1,687
-9% -$132K 0.01% 781
2025
Q3
$1.43M Buy
17,839
+4,161
+30% +$355K 0.01% 729
2025
Q2
$1.24M Buy
13,678
+1,608
+13% +$147K 0.01% 738
2025
Q1
$1.13M Buy
12,070
+933
+8% +$83.5K 0.01% 676
2024
Q4
$1.01M Buy
11,137
+1,652
+17% +$158K 0.01% 672
2024
Q3
$985K Sell
9,485
-1,463
-13% -$149K 0.01% 682
2024
Q2
$1.06M Buy
10,948
+676
+7% +$62.4K 0.01% 638
2024
Q1
$925K Sell
10,272
-1,766
-15% -$150K 0.01% 638
2023
Q4
$960K Buy
12,038
+768
+7% +$57.7K 0.01% 589
2023
Q3
$801K Buy
11,270
+568
+5% +$42.5K 0.01% 596
2023
Q2
$824K Buy
10,702
+2,903
+37% +$225K 0.01% 569
2023
Q1
$586K Buy
7,799
+870
+13% +$64.7K 0.01% 606
2022
Q4
$546K Sell
6,929
-851
-11% -$63.8K 0.01% 588
2022
Q3
$547K Buy
7,780
+133
+2% +$10.4K 0.01% 542
2022
Q2
$613K Buy
7,647
+11
+0.1% +$860 0.01% 513
2022
Q1
$579K Buy
7,636
+3,196
+72% +$253K 0.01% 539
2021
Q4
$379K Buy
4,440
+10
+0.2% +$781 0.01% 640
2021
Q3
$335K Buy
4,430
+50
+1% +$3.97K 0.01% 640
2021
Q2
$356K Buy
4,380
+117
+3% +$9.57K 0.01% 619
2021
Q1
$336K Sell
4,263
-499
-10% -$39.1K 0.01% 596
2020
Q4
$407K Sell
4,762
-711
-13% -$58.8K 0.01% 498
2020
Q3
$422K Sell
5,473
-73
-1% -$5.57K 0.01% 464
2020
Q2
$406K Buy
5,546
+1,954
+54% +$139K 0.01% 451
2020
Q1
$238K Buy
+3,592
New +$253K 0.01% 508

Other funds holding CL

Equitable Holdings's CL Position: Q2 2026 in Review

Equitable Holdings reduced its Colgate-Palmolive (CL) stake by 8.2% in Q2 2026, selling an estimated $225K and leaving 28,594 shares worth $2.62M. The position accounts for 0.02% of the portfolio, ranked #651.

Equitable Holdings first reported a position in CL in Q1 2020 and has held it in 26 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Equitable Holdings held 28,594 shares of Colgate-Palmolive worth $2.62M as of Q2 2026.
  • Equitable Holdings sold 2,568 Colgate-Palmolive shares in Q2 2026, an estimated $225K.
  • Colgate-Palmolive made up 0.02% of Equitable Holdings's portfolio in Q2 2026, its #651 holding.
  • Equitable Holdings first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 26 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.